Trials / Completed
CompletedNCT01327443
Exercise Versus Diet in the Treatment of Nonalcoholic Fatty Liver Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- University of Missouri-Columbia · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The central hypothesis of this proposal is that a reduction in hepatic mitochondrial function is the main pathophysiology behind NAFLD (Non-Alcoholic Fatty Liver Disease) and NASH (Non alcoholic steatohepatitis). The investigators further hypothesize that lifestyle modifications through aerobic exercise training without weight loss or diet-induced weight loss are effective in reducing NAFLD parameters by improving hepatic mitochondrial content and function in human subjects. The investigators propose a randomized, controlled human clinical trial to compare the effects of aerobic exercise training (without weight loss) versus diet-induced weight loss (without exercise) in individuals who have NAFLD or liver biopsy-confirmed NASH
Detailed description
Fatty Liver Disease) and NASH (Non alcoholic steatohepatitis). The investigators further hypothesize that lifestyle modifications through aerobic exercise training without weight loss or diet-induced weight loss are effective in reducing NAFLD parameters by improving hepatic mitochondrial content and function in human subjects. The investigators propose a randomized, controlled human clinical trial to compare the effects of aerobic exercise training (without weight loss) versus diet-induced weight loss (without exercise) in individuals who have NAFLD or liver biopsy-confirmed NASH
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Weight loss | Nutritional counseling |
| BEHAVIORAL | Exercise | Under direct supervision |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2012-09-01
- Completion
- 2015-10-01
- First posted
- 2011-04-01
- Last updated
- 2016-10-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01327443. Inclusion in this directory is not an endorsement.